In Vitro Diagnostic Packaging Market Summary
The global in vitro diagnostic packaging market size was valued at USD 9.30 billion in 2024 and is projected to reach USD 12.53 billion by 2030, growing at a CAGR of 5.1% from 2025 to 2030. The rising penetration of multi-featured human-machine interface (HMI) devices, increasing adoption of the Industrial Internet of Things (IIoT), and proliferation of smart industrial displays are some of the factors contributing to market growth.
Download Free Sample Ask for Discount Request Customization
Market Size & Trends
- Asia Pacific dominated the market and accounted for the largest revenue share of over 36.0% in 2024.
- The China IVD packaging market is growing due to its massive diagnostics industry, government support, and increasing healthcare expenditure.
- In terms of product type segment, bottles and vials recorded the largest market revenue share of over 40.0% in 2024.
- In terms of the application segment, hospitals recorded the largest market share at over 43.0% in 2024.
Key Market Statistics
- 2024 Market Size$9.30 Billion
- 2030 Estimated Market Size$12.53 Billion
- CAGR5.1% (2024-2030)
- Asia PacificLargest market in 2024 and fastest-growing region during the forecast period.
Further driving market expansion are strict regulatory requirements for the safe handling and transportation of samples. The growing need for diagnostic testing, particularly as a result of global health issues like the COVID-19 pandemic, is driving the in vitro diagnostic (IVD) packaging market. Investments in diagnostics are increasing as a result of the growing prevalence of chronic illnesses and infectious diseases as well as the increased focus on preventative healthcare. Manufacturers are increasing the production of diagnostic kits and reagents in response to the spike in test volumes, which calls for dependable, contaminant-proof, and user-friendly packaging solutions. For instance, the quick creation and widespread use of PCR and antigen test kits during the COVID-19 epidemic necessitated creative packaging that could facilitate mass dissemination without compromising sample integrity.
The growing popularity of home diagnostics and point-of-care (POC) testing is another factor driving market expansion. Compact, user-friendly package formats that provide simple handling without expert supervision are necessary for these applications. This demand compels packaging manufacturers to develop tamper-evident seals, sterile blister packs, and smart labels that track product authenticity or provide usage instructions. For example, diabetes IVD tests (such as blood glucose monitors) are increasingly being offered in portable, easy-to-transport versions that are appealing to both patients and medical practitioners.
In the IVD industry, packaging requirements are also heavily influenced by safety and regulatory compliance. Packaging needs to adhere to labeling regulations, provide chemical stability, and guard against contamination. High-barrier materials like multilayer films and medical-grade plastics have increased as a result of this trend. Strict regulatory frameworks, including the FDA's 21 CFR and the EU's IVDR, require packaging that guarantees traceability and reduces the possibility of diagnostic errors in places like the U.S. and the EU. To make tracking and compliance easier, IVD packaging has developed to incorporate RFID tags and serialized barcodes.
Furthermore, the future of IVD packaging is being shaped by sustainability considerations. Healthcare professionals examine medical waste management closely and seek eco-friendly alternatives. The movement promotes the creation of packaging materials that are recyclable, biodegradable, or reused without sacrificing sterility. For instance, some businesses are testing the use of plant-based polymers for blister card packaging and recyclable PCR tube trays. As hospitals and laboratories look to align with global sustainability standards, this trend toward sustainable practices is creating a competitive differentiation for package providers in the IVD industry.
Market Concentration & Characteristics
The market demonstrates a number of distinctive industry traits that are indicative of its interaction with specialist packaging technologies and the larger healthcare system. Its extensive regulatory control is one of its main features. Packaging for IVD goods must adhere to strict medical requirements for sterility, traceability, and labeling because these items have a direct impact on patient diagnosis and treatment. Materials used, shelf-life claims, and tamper-evidence features are regulated by organizations including the International Organization for Standardization (ISO), the European Medicines Agency (EMA), and the U.S. Food and Drug Administration (FDA). Because of this, producers in this sector work in a highly regulated environment, which makes it difficult for new competitors to enter.
The connection between the development of diagnostic technologies and innovative packaging is another important feature. As diagnostic tools get better, especially with new technologies like molecular diagnostics, microfluidics, and lab-on-a-chip systems, packaging needs to adapt to fit more fragile and complex parts. Customized, frequently single-use packaging solutions that can assist automation, maintain sample integrity, and provide user-friendly formats are highly sought after in such an environment. Consequently, manufacturers of diagnostic devices place significant emphasis on R&D, and they routinely collaborate with providers of specialized packaging.
Additionally, the business exhibits a high degree of global interconnectedness, with supply networks frequently spanning countries. Manufacturing and packaging activities take place in several locations, while raw materials like medical-grade polymers, foils, and adhesives are sourced worldwide. This worldwide reach is both a benefit and a drawback; while it allows for cost savings and scalability, it also leaves the industry vulnerable to pandemics, shipping delays, and geopolitical unrest. Businesses that make investments in geographical diversification and supply chain resilience frequently obtain a competitive advantage in the IVD packaging industry.
Report Coverage & Deliverables
The PDF report & online dashboard will help you understand
- Competitive benchmarking
- Historical data & forecasts
- Company revenue shares
- Regional opportunities
- Latest trends & dynamics
Product Type Insights
With a market revenue share of over 40.0% in 2024, the bottles and vials sector is expected to rise at the quickest compound annual growth rate (CAGR) of 5.5% over the course of the forecast period. Reagents, specimens, and solutions needed for IVD testing are contained in bottles and vials, which are crucial core packaging components. Bottles and vials, typically made of plastic or glass, serve to ensure the chemical stability of the materials they hold. Accurate diagnostics depend on these package options' precise volumetric control, sterility, and airtight sealing. The growing need for liquid-based diagnostic reagents and sample preservation drives the use of bottles and vials.
In IVD settings, tubes are frequently used for reagent handling, sample storage, centrifugation, and blood collection. These could contain PCR tubes or vacuum blood collection, depending on the use. To preserve sample integrity during testing and transportation, tubes are available in various sizes and closures. The need for tubes is driven by the increasing number of diagnostic procedures that use blood or biological fluids, such as tests for infectious diseases, cholesterol, and blood glucose. Growing clinical laboratories and rising healthcare spending, particularly in preventive diagnostics, further stimulate the market for IVD tubes.
Application Insights
In 2024, the hospital category had the most market share, accounting for about 43.0%. For disease diagnosis, emergency diagnostics, and patient monitoring, hospitals employ various diagnostic techniques. To guarantee the safety and dependability of test kits and reagents, these institutions need packaging that is sterile, tamper-evident, and long-lasting. Growing rates of chronic illness, more hospital admissions, and the incorporation of diagnostic services into treatment processes are the main drivers of the expansion of hospital-based diagnostics. Additionally, rising hospital infrastructure investments in emerging economies support the need for premium IVD packaging.
Over the course of the projection period, the academic institutes category is anticipated to develop at the quickest CAGR of 5.4%. Academic institutions and research centers use IVD packaging for research applications, teaching, and experimental diagnostics. They need adaptable, frequently small-batch packaging options that guarantee sample integrity and outcome reproducibility. Increased financing for biomedical research, corporate partnerships for research and development, and expanding interest in molecular biology and genomics are the main factors propelling academic institutes. These organizations frequently test out next-generation diagnostics, which increases demand for creative packaging designs.
Download Free Sample Ask for Discount Request Customization
Regional Insights
Asia Pacific dominated the market and accounted for the largest revenue share of over 36.0% in 2024. It is anticipated to grow at the fastest CAGR of 5.5% over the forecast period. We can attribute this dominance to its rapidly expanding healthcare infrastructure, increasing demand for diagnostic testing, and growing biotechnology investments. Countries such as China, India, and Japan are leading due to rising chronic diseases, government initiatives to improve healthcare access, and the expansion of diagnostic laboratories. For example, China’s 14th Five-Year Plan emphasizes strengthening its domestic IVD industry, boosting demand for high-quality packaging solutions.
China In Vitro Diagnostic Packaging Market Trends
The China IVD packaging market is growing due to its massive diagnostics industry, government support, and increasing healthcare expenditure. The country’s focus on local manufacturing (Made in China 2025) has reduced import dependency, fostering growth in domestic IVD packaging suppliers. The post-pandemic demand for PCR and rapid antigen tests has also driven innovations in lightweight and durable packaging to meet global supply chain needs.
North America In Vitro Diagnostic Packaging Market Trends
The region’s growth in the IVD Packaging market is primarily due to its advanced healthcare systems, stringent regulatory standards, and high adoption of innovative diagnostic technologies. The U.S. and Canada have well-established IVD industries that strongly focus on automation and sustainable packaging solutions. For instance, the FDA’s strict regulations on IVD packaging ensure high barrier protection and sterility, pushing companies to develop advanced materials like high-performance films and tamper-evident seals. The rise of personalized medicine and point-of-care testing (POCT) also fuels demand.
Europe In Vitro Diagnostic Packaging Market Trends
Europe’s growth in the IVD packaging market is driven by strict EU regulations, an aging population, and increasing diagnostic testing. Countries such as Germany, France, and the UK lead due to their strong medical device industries and emphasis on sustainable packaging solutions. The European In Vitro Diagnostic Regulation (IVDR) mandates high safety standards, pushing manufacturers to adopt recyclable and biocompatible materials. For example, Germany’s Roche Diagnostics and Siemens Healthineers use advanced polymer-based packaging to ensure product integrity. The growing prevalence of chronic and infectious diseases has also increased demand for IVD tests, further boosting the packaging sector.
Download Free Sample Ask for Discount Request Customization
Key In Vitro Diagnostic Packaging Company Insights
The IVD packaging market has a competitive environment characterized by several global and regional players striving to meet stringent regulatory standards, ensure product safety, and enhance user convenience. Key players compete in the innovation, quality, and sustainability of primary and secondary packaging materials. The market is somewhat concentrated, with companies focusing on eco-friendly packaging, features that show if a product has been tampered with, and strong barrier properties to meet the increasing need for dependable diagnostics, especially in point-of-care and molecular testing. Strategic partnerships, mergers, and acquisitions are also prevalent, as firms seek to expand their geographic reach and technological capabilities in an evolving healthcare landscape.
-
In October 2024, Nipro launched its innovative D2F (Direct-to-Fill) glass vials featuring Stevanato Group’s advanced EZ-fill technology, providing a high-quality ready-to-use (RTU) solution for the pharmaceutical industry. These vials are washed, depyrogenated, sterilized, and packaged in nest and tub formats that prevent glass-to-glass contact, reducing breakage, cosmetic defects, and particulate generation during handling and transport. This collaboration underscores Stevanato Group’s technological leadership and strengthens Nipro’s position in delivering premium primary pharma packaging solutions.
-
In February 2024, SGD Pharma launched a new range of high-quality Type I injectable vials made from tubular glass, featuring an external low-friction coating developed in partnership with Corning called Velocity Vial technology. This new coating greatly lowers the friction that happens when glass touches glass or metal during the filling of pharmaceuticals, which helps stop vials from tipping over, getting stuck, or breaking, and improves the efficiency of the filling line by 20–50%.
In Vitro Diagnostic Packaging Market Report Scope
|
Report Attribute |
Details |
|
Market size value in 2025 |
USD 9.76 billion |
|
Revenue forecast in 2030 |
USD 12.53 billion |
|
Growth rate |
CAGR of 5.1% from 2025 to 2030 |
|
Historical data |
2018-2023 |
|
Forecast period |
2025-2030 |
|
Quantitative units |
Revenue in USD million/billion and CAGR from 2025 to 2030 |
|
Report coverage |
Revenue forecast, competitive landscape, growth factors, and trends |
|
Segments covered |
Product type, application, region |
|
Regional scope |
North America; Europe; Asia Pacific; Latin America; Middle East & Africa |
|
Key companies profiled |
Amcor plc; AptarGroup Incorporated; Thermo Fisher Scientific Incorporated; Corning Incorporated; Greiner Holding AG; COMAR, LLC; WS Packaging Group; DWK Life Sciences; SCHOTT Poonawalla; SGD Pharma; Stevanato |
|
Customization scope |
We offer free report customization with every purchase, which is equivalent to up to 8 analysts' working days. You can add or alter the scope of the country, region, and segment. |
|
Pricing and purchase options |
Avail yourself of customized purchase options to meet your exact research needs. Explore purchase options |
Download Free Sample Ask for Discount Request Customization
Global In Vitro Diagnostic Packaging Market Report Segmentation
This report forecasts revenue growth at a global level and provides an analysis of the latest industry trends in each of the subsegments from 2018 to 2030. For this study, Grand View Research has segmented the global in vitro diagnostic (IVD) packaging market report based on product type, application, and region
-
Product Type Outlook (Revenue, USD Million, 2018-2030)
-
Bottles and Vials
-
Tubes
-
Petri Dishes
-
Labels & Stickers
-
Others
-
-
Application Outlook (Revenue, USD Million, 2018-2030)
-
Hospitals
-
Laboratories
-
Academic institutes
-
Others
-
-
Region Outlook (Revenue, USD Million, 2018-2030)
-
North America
-
U.S.
-
Canada
-
Mexico
-
-
Europe
-
Germany
-
France
-
UK
-
Italy
-
Spain
-
-
Asia Pacific
-
China
-
India
-
Japan
-
South Korea
-
Australia
-
-
Latin America
-
Brazil
-
Argentina
-
-
Middle East & Africa
-
South Africa
-
Saudi Arabia
-
UAE
-
-
Related Reports
FAQ'S
For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:
Within 24 to 48 hrs.
You can contact Sales team (sales@marketinsightsresearch.com) and they will direct you on email
You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.
Discounts are available.
Hard Copy